Home›Companies›Healthcare›Simbryo

Simbryo Technologies, Inc.

Fertility testing for patients and physicians using models of patients' uterine lining.

Updated Nov 10, 2026·Latest SEC filing Jul 27, 2026·Suggest an edit

About Simbryo

Simbryo is a private company based in Houston, Texas, incorporated in 2023 in Delaware. It has reported $5,250,972 raised in one offering on Form D since July 2026. Its chief executive is Yael Katz.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 26, 2025Jul 27, 2026$5,250,972of $5.2M target24$218KEquity, OptionsRule 506(b)Form D ↗

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Simbryo's Form D filed Jul 27, 2026.

Aryeh Warmflash
Aryeh Warmflash
Chief Science Officer
SR
Yael Katz
Yael Katz
Chief Executive Officer and director
Also a director at BrainCheck.

Sources

  1. SECSimbryo Technologies, Inc. filing history
  2. CompanyPrivacy Policy
  3. CompanyAbout Simbryo
  4. CompanySimbryo team